212 related articles for article (PubMed ID: 20655754)
1. Improved inhibition of the histone acetyltransferase PCAF by an anacardic acid derivative.
Ghizzoni M; Boltjes A; Graaf Cd; Haisma HJ; Dekker FJ
Bioorg Med Chem; 2010 Aug; 18(16):5826-34. PubMed ID: 20655754
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of benzamides related to anacardic acid and their histone acetyltransferase (HAT) inhibitory activities.
Souto JA; Conte M; Alvarez R; Nebbioso A; Carafa V; Altucci L; de Lera AR
ChemMedChem; 2008 Sep; 3(9):1435-42. PubMed ID: 18537201
[TBL] [Abstract][Full Text] [Related]
3. New anacardic acid-inspired benzamides: histone lysine acetyltransferase activators.
Souto JA; Benedetti R; Otto K; Miceli M; Alvarez R; Altucci L; de Lera AR
ChemMedChem; 2010 Sep; 5(9):1530-40. PubMed ID: 20683922
[TBL] [Abstract][Full Text] [Related]
4. Characterization of novel inhibitors of histone acetyltransferases.
Eliseeva ED; Valkov V; Jung M; Jung MO
Mol Cancer Ther; 2007 Sep; 6(9):2391-8. PubMed ID: 17876038
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of PCAF by anacardic acid derivative leads to apoptosis and breaks resistance to DNA damage in BCR-ABL-expressing cells.
Kusio-Kobialka M; Dudka-Ruszkowska W; Ghizzoni M; Dekker FJ; Piwocka K
Anticancer Agents Med Chem; 2013 Jun; 13(5):762-7. PubMed ID: 23157591
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of PCAF histone acetyltransferase and cytotoxic effect of N-acylanthranilic acids.
Park WJ; Ma E
Arch Pharm Res; 2012 Aug; 35(8):1379-86. PubMed ID: 22941480
[TBL] [Abstract][Full Text] [Related]
7. Enzyme kinetics and inhibition of histone acetyltransferase KAT8.
Wapenaar H; van der Wouden PE; Groves MR; Rotili D; Mai A; Dekker FJ
Eur J Med Chem; 2015 Nov; 105():289-96. PubMed ID: 26505788
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological testing of novel pyridoisothiazolones as histone acetyltransferase inhibitors.
Furdas SD; Shekfeh S; Bissinger EM; Wagner JM; Schlimme S; Valkov V; Hendzel M; Jung M; Sippl W
Bioorg Med Chem; 2011 Jun; 19(12):3678-89. PubMed ID: 21353783
[TBL] [Abstract][Full Text] [Related]
9. Histone acetyl transferases as emerging drug targets.
Dekker FJ; Haisma HJ
Drug Discov Today; 2009 Oct; 14(19-20):942-8. PubMed ID: 19577000
[TBL] [Abstract][Full Text] [Related]
10. Reactivity of isothiazolones and isothiazolone-1-oxides in the inhibition of the PCAF histone acetyltransferase.
Ghizzoni M; Haisma HJ; Dekker FJ
Eur J Med Chem; 2009 Dec; 44(12):4855-61. PubMed ID: 19683843
[TBL] [Abstract][Full Text] [Related]
11. Activation of p300 histone acetyltransferase by small molecules altering enzyme structure: probed by surface-enhanced Raman spectroscopy.
Mantelingu K; Kishore AH; Balasubramanyam K; Kumar GV; Altaf M; Swamy SN; Selvi R; Das C; Narayana C; Rangappa KS; Kundu TK
J Phys Chem B; 2007 May; 111(17):4527-34. PubMed ID: 17417897
[TBL] [Abstract][Full Text] [Related]
12. 6-alkylsalicylates are selective Tip60 inhibitors and target the acetyl-CoA binding site.
Ghizzoni M; Wu J; Gao T; Haisma HJ; Dekker FJ; George Zheng Y
Eur J Med Chem; 2012 Jan; 47(1):337-44. PubMed ID: 22100137
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of isothiazol-3-one derivatives as inhibitors of histone acetyltransferases (HATs).
Gorsuch S; Bavetsias V; Rowlands MG; Aherne GW; Workman P; Jarman M; McDonald E
Bioorg Med Chem; 2009 Jan; 17(2):467-74. PubMed ID: 19101154
[TBL] [Abstract][Full Text] [Related]
14. Identification of long chain alkylidenemalonates as novel small molecule modulators of histone acetyltransferases.
Sbardella G; Castellano S; Vicidomini C; Rotili D; Nebbioso A; Miceli M; Altucci L; Mai A
Bioorg Med Chem Lett; 2008 May; 18(9):2788-92. PubMed ID: 18434144
[TBL] [Abstract][Full Text] [Related]
15. Azide-alkyne cycloaddition affording enzymatically tunable bisubstrate based inhibitors of histone acetyltransferase PCAF.
van Ameijde J; Zwiebel AP; Ruijtenbeek R; Liskamp RM
Bioorg Med Chem Lett; 2014 Jan; 24(1):113-6. PubMed ID: 24345448
[TBL] [Abstract][Full Text] [Related]
16. Bisubstrate analogue structure-activity relationships for p300 histone acetyltransferase inhibitors.
Sagar V; Zheng W; Thompson PR; Cole PA
Bioorg Med Chem; 2004 Jun; 12(12):3383-90. PubMed ID: 15158807
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of histone acetyltransferase activity by anacardic acid sensitizes tumor cells to ionizing radiation.
Sun Y; Jiang X; Chen S; Price BD
FEBS Lett; 2006 Aug; 580(18):4353-6. PubMed ID: 16844118
[TBL] [Abstract][Full Text] [Related]
18. Phenylephrine-induced cardiac hypertrophy is attenuated by a histone acetylase inhibitor anacardic acid in mice.
Peng C; Luo X; Li S; Sun H
Mol Biosyst; 2017 Mar; 13(4):714-724. PubMed ID: 28194469
[TBL] [Abstract][Full Text] [Related]
19. Histone Acetyltransferase (HAT) P300/CBP Inhibitors Induce Synthetic Lethality in PTEN-Deficient Colorectal Cancer Cells through Destabilizing AKT.
Liu Y; Yang EJ; Shi C; Mou PK; Zhang B; Wu C; Lyu J; Shim JS
Int J Biol Sci; 2020; 16(11):1774-1784. PubMed ID: 32398948
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the activity of histone acetyltransferases by long chain alkylidenemalonates (LoCAMs).
Milite C; Castellano S; Benedetti R; Tosco A; Ciliberti C; Vicidomini C; Boully L; Franci G; Altucci L; Mai A; Sbardella G
Bioorg Med Chem; 2011 Jun; 19(12):3690-701. PubMed ID: 21292492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
